SCHEMBL4669235

SCHEMBL4669235

N#Cc1ccc(CCOCCN2CC3CN(CCNC(=O)O)CC(C2)O3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.44
HTR1A P08908 6/20 0.42
HRH1 P35367 5/20 0.42
OPRM1 P35372 4/20 0.42
DRD4 P21917 3/20 0.42
HTR2A P28223 3/20 0.42
DRD2 P14416 5/20 0.41
HTR7 P34969 5/20 0.41
HTR6 P50406 5/20 0.41
HRH2 P25021 4/20 0.41
CACNA1F O60840 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
DRD1 P21728 2/20 0.41
DRD5 P21918 2/20 0.41
ADRA1D P25100 2/20 0.41
ADRA1A P35348 2/20 0.41
ADRA1B P35368 2/20 0.41
DRD3 P35462 2/20 0.41
CACNA1D Q01668 2/20 0.41
SLC6A3 Q01959 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4668152 0.91 KCNH2 (0.44) KCNH2HTR1AHRH1OPRM1DRD4
SCHEMBL4125747 0.89 KCNH2 (0.48) KCNH2DRD2DRD3CNR1CD274
SCHEMBL2967590 0.89 KCNH2 (0.44) KCNH2HTR1AHRH1OPRM1DRD4
SCHEMBL4669237 0.88 KCNH2 (0.52) KCNH2HRH1HRH2KDM4EALDH1A1
SCHEMBL4134193 0.85 KCNH2 (0.53) KCNH2HRH1HRH2CD274KDM4E
SCHEMBL1619458 0.85 FAAH (0.46) KCNH2DRD2DRD3CD274ALDH1A1
SCHEMBL4137801 0.84 KCNH2 (0.59) KCNH2HRH1HRH2HRH3
SCHEMBL4669141 0.83 OPRM1 (0.44) KCNH2HTR1AHRH1OPRM1DRD4
SCHEMBL1619409 0.81 KCNH2 (0.54) KCNH2HRH1HRH2HRH3
SCHEMBL5318392 0.81 CD274 (0.58) KCNH2DRD2DRD3SIGMAR1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893619-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTMIAS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2006135316-A1 New oxabispidine compounds for the treatment of cardiac arrhythmias ASTRAZENECA AB (SE) 2006-12-21 WO disclosed